-
[1] De Backer G., Ambrosionie E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). http://www.escardio.org/guidelines-surveys/escguidelines/GuidelinesDocuments/guidelines-CVDprevention.pdf. 14.3.2013
-
[2] Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al., European guidelines on cardiovascular disease prevention in clinical practice: executive summary, EJCPR., 2007, 14, 1–113
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
[6] Tuncman G., Erbay E., Hom X., De Vivo I., Campos H., Rimm E.B., et al., A genetic variant at the fatty acid binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease, Proc. Natl. Acad. Sci. USA., 2005, 103, 6970–6975 http://dx.doi.org/10.1073/pnas.0602178103
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME